moatshark My

All holdings

Fresenius Medical Care

FMS

Also listed on its home exchange as FME (GR), where funds report holdings that 13F filings leave out.

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$86.5m
Combined value at quarter end
Last quarter
0 bought
0 sold or trimmed
Price at Q2 ’26 end
$22.61
+0.2% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+11.6%Q3 ’24
+6.3%Q4 ’24
+10.0%Q1 ’25
+14.7%Q2 ’25
-7.8%Q3 ’25
-9.5%Q4 ’25
-5.3%Q1 ’26
+0.2%Q2 ’26
Q3 ’24: +11.6%; Q4 ’24: +6.3%; Q1 ’25: +10.0%; Q2 ’25: +14.7%; Q3 ’25: -7.8%; Q4 ’25: -9.5%; Q1 ’26: -5.3%; Q2 ’26: +0.2%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

1Q4 ’23
1Q1 ’24
1Q2 ’24
1Q3 ’24
1Q4 ’24
2Q1 ’25
2Q2 ’25
1Q3 ’25
1Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Q4 ’23: 1; Q1 ’24: 1; Q2 ’24: 1; Q3 ’24: 1; Q4 ’24: 1; Q1 ’25: 2; Q2 ’25: 2; Q3 ’25: 1; Q4 ’25: 1; Q1 ’26: 1; Q2 ’26: 1; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Fresenius Medical Care.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Fresenius Medical Care
Dodge & Cox0.1%$86.5m$86.5mUnchanged18 qtrs

Download the holders: CSV · JSON · Markdown

Held through its listing in Xetra (FME)

The same company’s shares listed in Xetra, held in the full portfolios of US-registered funds (N-PORT). A 13F can’t show these. See the FME page.

Funds holding Fresenius Medical Care through FME
Dodge & Cox International Stock FundDodge & Cox0.9%Trimmed -2.0%$622m
Dodge & Cox Global Stock FundDodge & Cox0.9%Unchanged$118m

About the company

Sector
Health care · Services-Misc Health & Allied Services, Nec
Shares outstanding
279m at 31 Dec 2025
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$5.0bn2013
$5.3bn2014
2015
2016
2013: $5.0bn; 2014: $5.3bn; 2015: not held; 2016: not held
Fresenius Medical Care revenue and net income by year
YearRevenueNet income
2016–$1.2bn
2015–$1.0bn
2014$5.3bn$1.0bn
2013$5.0bn$1.1bn

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.